The IgG Fab fragment inhibitors belong to a distinctive chemical class primarily designed to target and modulate the function of the immunoglobulin G (IgG) antibody's antigen-binding fragment (Fab). IgG antibodies play a pivotal role in the immune system, recognizing and binding to specific antigens, thereby triggering immune responses. The Fab fragment, also known as the antigen-binding fragment, constitutes one of the two arms of the Y-shaped IgG molecule. It is responsible for recognizing and binding to the specific epitope of an antigen, facilitating the antibody's immune function. The inhibitors designed for this specific fragment aim to interfere with the normal binding process, thereby influencing the overall immune response. These inhibitors are meticulously engineered to selectively interact with the Fab region of the IgG antibody, disrupting its ability to recognize and attach to antigens effectively.
IgG Fab fragment inhibitors represent a sophisticated approach in molecular biology and immunology research. By targeting the Fab region, researchers can gain insights into the precise mechanisms underlying immune responses and potentially control or modulate immune reactions. This class of inhibitors may find applications in various experimental settings where fine-tuning the immune response is crucial for understanding specific aspects of immunity. The design and study of IgG Fab fragment inhibitors contribute to advancing our understanding of immune system dynamics and may pave the way for innovative strategies in manipulating immune responses for research purposes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Alkylating agent that can lead to reduced antibody production by causing cytotoxicity in B-cells. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Folate pathway antagonist that can suppress the immune system, thus potentially decreasing antibody production. | ||||||
Mycophenolate mofetil | 128794-94-5 | sc-200971 sc-200971A | 20 mg 100 mg | $37.00 $109.00 | 1 | |
Inhibits inosine monophosphate dehydrogenase, leading to a reduction in proliferation of B-cells and antibody levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can suppress B-cell proliferation and consequently antibody production. | ||||||
Chlorambucil | 305-03-3 | sc-204682 sc-204682A | 250 mg 1 g | $52.00 $122.00 | 3 | |
Another alkylating agent that can impair B-cell function and reduce antibody production. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Can modulate immune activity, possibly affecting antibody production or function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can lead to apoptosis of plasma cells, reducing antibody levels. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin inhibitor that can suppress T-cell help to B-cells, potentially reducing antibody production. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Purine synthesis inhibitor that can decrease proliferation of B-cells and thus antibody production. | ||||||
Fludarabine | 21679-14-1 | sc-204755 sc-204755A | 5 mg 25 mg | $58.00 $204.00 | 15 | |
Purine analog that can lead to decreased B-cell proliferation and antibody production. | ||||||